Non-investigational medical products
In this trial, it is medically necessary in most cases for clinical trial subjects to receive a multi-drug immunosuppressive regimen to prevent allograft rejection. Therefore, in addition to IMP, patients will be treated with a therapy of several other immunosuppressive agents, regardless of randomisation group. All systemic immunosuppressive therapy given will be collected in the eCRF.The following substances are prohibited during study participation:CyclosporineAny tacrolimus preparation other than the assigned IMP (excluding immediate-release formulations taken prior to randomisation or during an acute rejection episode or in place of the IMP during a temporary interruption of IMP)St. John’s wort (Grapefruit and grapefruit juice